expansion
Incyte Unveils Promising Monjuvi Data at ASH24, Paving Way for FDA Label Expansion in Follicular Lymphoma
Incyte, Monjuvi, ASH24, Follicular Lymphoma, Label Expansion, FDA, Phase 3 Trial
GSK Invests $800 Million in Pennsylvania Site Expansion to Boost Vaccine and Medicine Production
GSK, Pennsylvania, manufacturing expansion, vaccine production, medicine manufacturing, $800 million investment
Nucleus RadioPharma Unveils Ambitious Expansion Plan to Triple Production Capacity and Create 100 New Positions
Nucleus RadioPharma, Radiopharma CDMO, Manufacturing Expansion, Job Creation, Radiopharmaceuticals, Radiotherapeutics
Catalent Sells New Jersey Facility and HQ to Ardena, Expanding Belgian CDMO’s US Footprint
Catalent, Ardena, New Jersey manufacturing plant, HQ sale, CDMO expansion, pharmaceutical manufacturing
Bayer Seeks to Broaden Nubeqa’s Use in Prostate Cancer with Chemotherapy-Free Treatment Option
Nubeqa, Bayer, prostate cancer, chemotherapy-free, label expansion, ARANOTE trial, darolutamide, androgen deprivation therapy (ADT), metastatic hormone-sensitive prostate cancer (mHSPC)
Eli Lilly Expands Irish Manufacturing with Additional $1B Investment
Eli Lilly, Ireland, manufacturing expansion, biologics, pharmaceuticals, investment, Limerick, Kinsale
Novartis Expands Radioligand Therapy Production with Two New US Facilities
Novartis, radioligand therapy, RLT, cancer treatment, manufacturing facilities, US expansion
AstraZeneca Invests $135M in Swedish Biologics Manufacturing Expansion
AstraZeneca, biologics manufacturing, Sweden, expansion, investment
Aadi Bioscience Cuts 80% of R&D Staff Amid Fyarro Expansion Setbacks
Aadi Bioscience, R&D workforce, Fyarro, expansion efforts, layoffs, pharmaceutical industry
Incyte Seeks Expanded Approval for Monjuvi Following Successful Phase III Trial in Follicular Lymphoma
Incyte, Monjuvi, follicular lymphoma, Phase III trial, label expansion, tafasitamab, MorphoSys, FDA approval, cancer treatment.